SYNEOS HEALTH, INC. SYNH Cash Flow

Syneos health, inc. (SYNH)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12
Cash flows from operating activities:
Net income (loss)
131,258	24,284	-138,469	112,630	117,047	-23,470	-41,529	-59,114
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization
242,465	273,685	179,936	59,204	56,014	54,543	58,473	78,811
Stock repurchase costs
-	-	-	-	1,637	0	0	-
Amortization of Senior Notes premium, net of capitalized loan fees and original issue discount
-	-	-	-	1,346	5,700	7,073	5,165
Share-based compensation
55,193	34,323	59,696	14,020	5,074	3,370	2,419	1,248
Provision for doubtful accounts
1,897	-4,587	4,167	2,570	-144	2,435	77	777
Provision for deferred income taxes
-40,069	240	14,431	-22,260	4,134	-14,837	3,646	-45,195
Foreign currency transaction gains
-11,166	16,165	-7,912	-20,681	795	7,390	-409	2,474
Asset impairment charges
0	0	30,000	0	3,931	17,245	0	-
Fair value adjustment of contingent obligations
17,260	-11,590	-12,276	0	0	-	-	-
Loss on extinguishment of debt
10,395	-4,153	-622	-439	-9,795	-49,227	0	0
Gain on purchase of equity affiliate
-	-	-	-	-	-	-	2,735
Impairment of goodwill and intangible assets
-	-	-	-	-	-	-	4,000
Excess income tax benefits from share-based awards
-	-	-	-	975	0	0	-
Other non-cash items
-2,766	-2,849	-5,212	-1,258	82	853	-477	-3,404
Changes in operating assets and liabilities:
Accounts receivable, unbilled services, and deferred revenue
120,389	97,621	-60,623	99,688	54,073	24,259	2,537	-37,537
Restricted cash
-	-	-	-	-	-	-	-1,530
Accounts payable and accrued expenses
28,316	60,024	-16,982	6,658	8,186	25,743	-438	-2,105
Deferred revenue
-	-	-	-	68,500	42,742	7,036	8,363
Other assets and liabilities
987	-33,853	-3,386	-13,978	14,855	-1,251	-2,164	-13,787
Net cash used in operating activities
318,481	303,448	198,258	109,490	204,740	131,447	37,270	42,999
Cash flows from investing activities:
Payments associated with business combinations, net of cash acquired
712	90,890	1,678,381	0	0	2,302	0	3,383
Purchases of property and equipment
63,973	54,595	43,896	31,353	21,111	25,551	17,714	9,591
Investments in unconsolidated affiliates
16,976	0	0	-	-	-	-	-
Other, net
0	0	567	0	0	-	-	-
Net cash used in investing activities
-81,661	-145,485	-1,722,844	-31,353	-21,111	-27,853	-17,714	-12,974
Cash flows from financing activities:
Proceeds from issuance of long-term debt, net of discount
582,000	0	2,598,000	0	525,000	288,365	2,835	0
Payments of debt financing costs
2,636	3,062	25,476	868	4,987	5,364	0	0
Repayments of long-term debt
437,936	390,646	525,097	0	475,001	164,095	3,520	10,000
Proceeds from accounts receivable financing agreement
127,815	187,700	0	0	-	-	-	-
Repayments of accounts receivable financing agreement
22,400	18,300	0	0	-	-	-	-
Proceeds from revolving line of credit
0	0	15,000	100,000	45,000	0	0	-
Repayments of revolving line of credit
0	0	40,000	105,000	15,000	0	0	-
Redemption of Senior Notes and associated breakage fees
418,112	0	292,425	0	0	336,385	0	0
Payments of contingent consideration related to business combinations
178	23,102	0	0	973	0	1,266	2,663
Payments of finance leases
14,493	15,423	8,145	0	452	2,680	3,307	3,420
Payments of stock repurchase costs
-	-	-	-	1,423	0	0	-
Payments for repurchases of common stock
56,716	74,985	0	64,500	285,000	38	1,390	2,755
Proceeds from the issuance of common stock
-	-	-	-	-	156,113	0	375
Proceeds from exercises of stock options
40,322	21,821	19,335	17,891	3,656	145	307	31
Payments related to tax withholdings for share-based compensation
13,135	3,359	6,824	839	3,194	0	0	-
Excess income tax benefits from share-based awards
-	-	-	-	975	0	0	-
Dividends paid
-	-	-	-	-	375	500	500
Redemption of New Class C and D common stock
-	-	-	-	-	3,384	0	0
Net cash provided by (used in) financing activities
-215,469	-319,356	1,734,368	-53,316	-211,399	-67,698	-6,841	-18,932
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
-13,594	-4,651	9,116	-7,206	-13,672	-6,415	2,894	-690
Net change in cash, cash equivalents, and restricted cash
7,757	-166,044	218,898	17,615	-41,442	29,481	15,609	10,403
Supplemental disclosure of cash flow information
Cash paid for income taxes
-	-	-	-	8,251	6,304	2,896	3,419
Cash paid for interest
-	-	-	-	17,533	64,347	54,191	57,035
Supplemental disclosures of non-cash investing activities:
Fair value of shares issued and share-based awards assumed in business combinations
-	-	-	-	0	-	-	-
Purchases of property and equipment included in liabilities
-	-	-	-	2,869	-	-	-
Vehicles acquired through capital lease agreements
-	-	-	-	0	-	470	713